RDGL
Vivos Inc.
Price Chart
Latest Quote
$0.06
-0.01 (-7.67%)
Current Price
| Previous Close | $0.07 |
| Open | $0.07 |
| Day High | $0.07 |
| Day Low | $0.06 |
| Volume | 744,270 |
Stock Information
| Shares Outstanding | 493.89M |
| Total Debt | $110K |
| Cash Equivalents | $2.53M |
| Revenue | $78K |
| Net Income | $-3.42M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $30.32M |
| EPS (TTM) | $-0.01 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $37.01M |
| Sales | $78K |
| Income | $-3.42M |
| Book/sh | $-0.02 |
| Cash/sh | $0.01 |
| Employees | 1 |
Financial Ratios
| Quick Ratio | 14.75 |
| Current Ratio | 15.14 |
| Debt/Eq | 4.06 |
Returns & Margins
| ROA | -56.92% |
| ROE | -116.12% |
| Gross Margin | -75.54% |
| Operating Margin | -1512.40% |
Ownership
| Insider Ownership | 4.17% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 390.29 |
| P/B | -3.61 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.07 |
| SMA50 | $0.07 |
| SMA200 | $0.08 |
| RSI | 34.08 |
| ATR | 0.0064 |
| Shares Float | 472.36M |
| Rel Volume | 1.07 |
Performance History
| Week | +1.15% |
| Month | -9.44% |
| Quarter | -31.47% |
| 6 Months | -14.72% |
| YTD | -10.36% |
| Year | -48.32% |
| 3 Years | +12.04% |
| 5 Years | -43.85% |
| 10 Years | -98.13% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $0.06 | 744,270 |
| 2026-06-15 | $0.07 | 419,019 |
| 2026-06-12 | $0.06 | 642,129 |
| 2026-06-11 | $0.06 | 489,419 |
| 2026-06-10 | $0.06 | 387,576 |
| 2026-06-09 | $0.06 | 738,974 |
| 2026-06-08 | $0.06 | 548,250 |
| 2026-06-05 | $0.06 | 1,388,243 |
| 2026-06-04 | $0.06 | 348,193 |
| 2026-06-03 | $0.06 | 1,757,878 |
| 2026-06-02 | $0.06 | 1,173,811 |
| 2026-06-01 | $0.07 | 757,395 |
| 2026-05-29 | $0.07 | 1,019,778 |
| 2026-05-28 | $0.07 | 39,365 |
| 2026-05-27 | $0.07 | 382,004 |
| 2026-05-26 | $0.07 | 744,307 |
| 2026-05-22 | $0.07 | 430,061 |
| 2026-05-21 | $0.07 | 1,176,629 |
| 2026-05-20 | $0.07 | 673,071 |
| 2026-05-19 | $0.06 | 83,296 |
| 2026-05-18 | $0.06 | 420,219 |
About Vivos Inc.
Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; PrecisionGel, a hydrogel polymer platform for delivering active pharmaceutical ingredients and therapeutic agents; Duncan Chiller, a general laboratory equipment for non-water localized chilling; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Peltier Chiller brands. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $30,979 | $25,536 | $28,779 | $12,000 |
| Cost Of Revenue | $30,979 | $25,536 | $28,779 | $12,000 |
| Total Revenue | $27,995 | $19,500 | $36,499 | $14,887 |
| Operating Revenue | $27,995 | $19,500 | $36,499 | $14,887 |
| Expenses | ||||
| Total Expenses | $2,632,379 | $2,812,646 | $2,554,248 | $2,516,685 |
| Other Income Expense | $-381,000 | $-151,184 | $47,588 | $-593 |
| Net Non Operating Interest Income Expense | $74,936 | $49,577 | $0 | $-25,375 |
| Operating Expense | $2,601,400 | $2,787,110 | $2,525,469 | $2,504,685 |
| General And Administrative Expense | $2,276,771 | $2,054,412 | $2,181,667 | $2,217,837 |
| Other Non Operating Income Expenses | - | $-151,184 | - | - |
| Interest Expense | - | - | $0 | $25,375 |
| Interest Expense Non Operating | - | - | $0 | $25,375 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Net Interest Income | $74,936 | $49,577 | $0 | $-25,375 |
| Interest Income | $74,936 | $49,577 | $0 | - |
| Normalized Income | $-2,529,448 | $-2,743,569 | $-2,517,749 | $-2,527,173 |
| Net Income From Continuing And Discontinued Operation | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Total Operating Income As Reported | $-2,604,384 | $-2,793,146 | $-2,517,749 | $-2,501,798 |
| Net Income Common Stockholders | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Net Income | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Net Income Including Noncontrolling Interests | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Net Income Continuous Operations | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Pretax Income | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Interest Income Non Operating | $74,936 | $49,577 | $0 | - |
| Operating Income | $-2,604,384 | $-2,793,146 | $-2,517,749 | $-2,501,798 |
| Gross Profit | $-2,984 | $-6,036 | $7,720 | $2,887 |
| Special Income Charges | - | $0 | $47,588 | $-593 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Basic EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,223,384 | $-2,641,962 | $-2,565,337 | $-2,501,798 |
| Total Unusual Items | $-381,000 | $-151,184 | $47,588 | $-593 |
| Total Unusual Items Excluding Goodwill | $-381,000 | $-151,184 | $47,588 | $-593 |
| EBITDA (Bullshit earnings) | $-2,604,384 | $-2,793,146 | $-2,517,749 | $-2,502,391 |
| EBIT | $-2,604,384 | $-2,793,146 | $-2,517,749 | $-2,502,391 |
| Diluted Average Shares | $409,673,533 | $368,805,214 | $351,425,912 | $325,851,906 |
| Basic Average Shares | $409,673,533 | $368,805,214 | $351,425,912 | $325,851,906 |
| Diluted NI Availto Com Stockholders | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-381,000 | $-151,184 | - | - |
| Research And Development | $324,629 | $732,698 | $343,802 | $286,848 |
| Selling General And Administration | $2,276,771 | $2,054,412 | $2,181,667 | $2,217,837 |
| Other Gand A | $1,924,174 | $1,772,696 | $1,906,427 | $1,950,360 |
| Salaries And Wages | $352,597 | $281,716 | $275,240 | $267,477 |
| Other Special Charges | - | - | $-47,588 | $593 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,147,247 | $1,365,120 | $1,661,044 | $1,467,383 |
| Total Assets | $2,233,456 | $1,610,124 | $1,742,736 | $1,634,298 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $2,233,456 | $1,610,124 | $1,742,736 | $1,634,298 |
| Prepaid Assets | $10,582 | $10,837 | $25,671 | $28,175 |
| Receivables | $10,326 | $7,000 | $11,000 | $0 |
| Accounts Receivable | $10,326 | $7,000 | $11,000 | $0 |
| Cash Cash Equivalents And Short Term Investments | $2,212,548 | $1,592,287 | $1,706,065 | $1,606,123 |
| Cash And Cash Equivalents | $2,212,548 | $1,592,287 | $1,706,065 | $1,606,123 |
| Cash Financial | $2,212,548 | $1,592,287 | $1,706,065 | $1,606,123 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $86,209 | $245,004 | $81,692 | $166,915 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $86,209 | $245,004 | $81,692 | $166,915 |
| Payables And Accrued Expenses | $86,209 | $245,004 | $81,692 | $166,915 |
| Payables | - | $245,004 | $81,692 | $166,915 |
| Accounts Payable | - | $245,004 | $81,692 | $166,915 |
| Current Notes Payable | - | - | - | $0 |
| Interest Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $2,144,791 | $1,362,464 | $1,658,388 | $1,464,727 |
| Preferred Stock Equity | $2,456 | $2,656 | $2,656 | $2,656 |
| Total Equity Gross Minority Interest | $2,147,247 | $1,365,120 | $1,661,044 | $1,467,383 |
| Stockholders Equity | $2,147,247 | $1,365,120 | $1,661,044 | $1,467,383 |
| Other Equity Interest | $-1,500 | - | - | - |
| Retained Earnings | $-85,361,229 | $-82,450,781 | $-79,556,028 | $-77,085,867 |
| Other | ||||
| Ordinary Shares Number | $440,873,806 | $387,894,033 | $362,541,528 | $343,530,678 |
| Share Issued | $440,873,806 | $387,894,033 | $362,541,528 | $343,530,678 |
| Tangible Book Value | $2,144,791 | $1,362,464 | $1,658,388 | $1,464,727 |
| Invested Capital | $2,144,791 | $1,362,464 | $1,658,388 | $1,464,727 |
| Working Capital | $2,147,247 | $1,365,120 | $1,661,044 | $1,467,383 |
| Total Capitalization | $2,147,247 | $1,365,120 | $1,661,044 | $1,467,383 |
| Additional Paid In Capital | $87,066,646 | $83,425,351 | $80,851,875 | $78,207,063 |
| Capital Stock | $443,330 | $390,550 | $365,197 | $346,187 |
| Common Stock | $440,874 | $387,894 | $362,541 | $343,531 |
| Preferred Stock | $2,456 | $2,656 | $2,656 | $2,656 |
| Current Accrued Expenses | - | - | - | $0 |
| Dueto Related Parties Current | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,684,039 | $-1,293,023 | $-1,120,058 | $-963,819 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,684,039 | $-1,293,023 | $-1,120,058 | $-963,819 |
| Cash Flow From Continuing Operating Activities | $-1,684,039 | $-1,293,023 | $-1,120,058 | $-963,819 |
| Operating Gains Losses | $381,000 | $151,184 | - | $-136,445 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,284,950 | $1,179,245 | $1,220,000 | $1,811,238 |
| Financing Cash Flow | $2,304,300 | $1,179,245 | $1,220,000 | $1,666,238 |
| Cash Flow From Continuing Financing Activities | $2,304,300 | $1,179,245 | $1,220,000 | $1,666,238 |
| Net Common Stock Issuance | $2,284,950 | $1,179,245 | $1,220,000 | $1,811,238 |
| Common Stock Issuance | $2,284,950 | $1,179,245 | $1,220,000 | $1,811,238 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-40,949 | $0 | $0 | $-145,000 |
| Issuance Of Debt | $40,949 | $0 | - | $0 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $50,773 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,212,548 | $1,592,287 | $1,706,065 | $1,606,123 |
| Beginning Cash Position | $1,592,287 | $1,706,065 | $1,606,123 | $903,704 |
| Changes In Cash | $620,261 | $-113,778 | $99,942 | $702,419 |
| Proceeds From Stock Option Exercised | $19,350 | $0 | - | - |
| Net Issuance Payments Of Debt | $0 | $0 | $0 | $-145,000 |
| Net Short Term Debt Issuance | $40,949 | $0 | - | - |
| Short Term Debt Issuance | $40,949 | $0 | - | - |
| Net Long Term Debt Issuance | $-40,949 | $0 | $0 | $-145,000 |
| Long Term Debt Payments | $-40,949 | $0 | $0 | $-145,000 |
| Change In Working Capital | $-161,866 | $210,596 | $3,111 | $-54,402 |
| Change In Payables And Accrued Expense | $-158,795 | $191,762 | $11,607 | $-60,062 |
| Change In Payable | $-158,795 | $191,762 | $11,607 | $31,480 |
| Change In Account Payable | $-158,795 | $191,762 | $11,607 | $31,480 |
| Change In Prepaid Assets | $255 | $14,834 | $2,504 | $5,660 |
| Change In Receivables | $-3,326 | $4,000 | $-11,000 | $0 |
| Changes In Account Receivables | $-3,326 | $4,000 | $-11,000 | $0 |
| Other Non Cash Items | $1,007,275 | $1,239,950 | $1,346,992 | $1,754,794 |
| Gain Loss On Investment Securities | $381,000 | $151,184 | - | - |
| Net Income From Continuing Operations | $-2,910,448 | $-2,894,753 | $-2,470,161 | $-2,527,766 |
| Change In Accrued Expense | - | - | $0 | $-91,542 |
| Change In Interest Payable | - | - | $0 | $-25,399 |
| Preferred Stock Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-02-02